BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2190232)

  • 21. Effects of alpha and beta adrenergic blockade on coronary arterial microvessels in the beating canine heart.
    Sekiguchi N; Kanatsuka H; Komaru T; Akai K; Sato K; Wang Y; Sugi M; Ashikawa K; Takishima T
    Cardiovasc Res; 1992 Apr; 26(4):415-21. PubMed ID: 1353415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of radiocontrast and endothelin administration on systolic blood pressure and renal damage in male spontaneously hypertensive and Wistar Kyoto rats with phentolamine-induced adrenergic blockade.
    Duarte CG; Zhang J; Ellis S
    Invest Radiol; 1998 Feb; 33(2):104-12. PubMed ID: 9493726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin antagonists block alpha1-adrenergic constriction of coronary arterioles.
    DeFily DV; Nishikawa Y; Chilian WM
    Am J Physiol; 1999 Mar; 276(3):H1028-34. PubMed ID: 10070088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional haemodynamic effects of carbachol injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.
    Bachelard H; Gardiner SM; Kemp PA; Bennett T
    Neuropharmacology; 1994 Jun; 33(6):769-88. PubMed ID: 7936115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of dopamine receptor and adrenoceptor blockade on the hemoconcentrating and hypotensive actions of atrial natriuretic peptide.
    Valentin JP; Ribstein J; Nafrialdi N; Mimran A
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1142-7. PubMed ID: 9365827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise-induced pulmonary vasoconstriction during combined blockade of nitric oxide synthase and beta adrenergic receptors.
    Kane DW; Tesauro T; Koizumi T; Gupta R; Newman JH
    J Clin Invest; 1994 Feb; 93(2):677-83. PubMed ID: 7509345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.
    Cryer PE; Rizza RA; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1114-8. PubMed ID: 6107816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular actions of endothelin in the rabbit kidney.
    Denton KM; Anderson WP
    Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):861-72. PubMed ID: 2092953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats.
    Madeddu P; Troffa C; Glorioso N; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV; Anania V
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):818-25. PubMed ID: 2481767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of BQ-123 on systemic and renal hemodynamic responses to endothelin-1 in the rat split hydronephrotic kidney.
    Cavarape A; Bartoli E
    J Hypertens; 1998 Oct; 16(10):1449-58. PubMed ID: 9814615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD; Allcock GH; Vane JR
    Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous morphine infusion (IMF) to drug-naive, conscious rats evokes bradycardic, hypotensive effects, but pressor actions are elicited after IMF to rats previously given morphine.
    Thornhill JA; Townsend C; Gregor L
    Can J Physiol Pharmacol; 1989 Mar; 67(3):213-22. PubMed ID: 2743208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of propranolol, practolol and butoxamine in pentobarbital-anesthetized rats.
    Shibouta Y; Nishikawa K; Kikuchi S; Shimamoto K
    Eur J Pharmacol; 1979 Jan; 53(2):201-8. PubMed ID: 759198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pressor response to beta 1- and beta 2-blockers in conscious rats treated with phentolamine.
    Tabrizchi R; King KA; Pang CC
    Pharmacology; 1988; 37(6):385-93. PubMed ID: 2907626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated cardiac, renal, and endocrine actions of endothelin.
    Miller WL; Redfield MM; Burnett JC
    J Clin Invest; 1989 Jan; 83(1):317-20. PubMed ID: 2642921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal effects of alpha-adrenoceptor blockade during furosemide diuresis in conscious rats.
    Petersen JS; Shalmi M; Abildgaard U; Christensen NJ; Christensen S
    Pharmacol Toxicol; 1992 Jan; 70(1):3-12. PubMed ID: 1350673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin: a potent renal and systemic vasoconstrictor peptide.
    King AJ; Brenner BM; Anderson S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1051-8. PubMed ID: 2660593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressor and heart rate responses to systemic administration of bombesin in anesthetized rats.
    Kaczyńska K; Szereda-Przestaszewska M
    Pharmacol Rep; 2011; 63(2):448-54. PubMed ID: 21602600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of adrenaline-induced hyperglycaemia in the anaesthetized cat by continuous infusion of phentolamine and propranolol.
    Al-Jibouri LM; Furman BL; Parratt JR
    Br J Pharmacol; 1980 Mar; 68(3):461-6. PubMed ID: 7052338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.